Heart Rhythm Society and sunny San Diego brought together the biggest HRS in years, with everything from custom presentation theaters to exciting afterparties. We hope everyone who attended HRS 2025 had as much fun as we did, and we hope all of you enjoy these top-six takeaways from electrophysiology’s biggest weekend of the year.
HRS Keeps Growing – The HRS annual meeting surpassed its pre-COVID numbers, as HRS 2025 crossed the 10k attendee mark (up from 9,588 last year), and the conference’s packed exhibit hall reflected the new growth.
Goodbye RFA, Hello PFA – Pulsed field ablation stepped on stage last year, but it’s now the star in the spotlight, with every major biotech firm touting a PFA device, and even Kardium, an independent contender aiming to best them all in design and outcomes.
EP’s Data Boom – As EP’s scientific studies grow, the thirst for data inspired several device data management companies to show up this year, as they offered up new ways to process procedural and ECG data for researchers and clinicians alike.
PFA and Pacemaker Results – HRS’ late breaker presentations were dominated by PFA safety and efficacy studies with a smattering of pacemaker studies targeting the left bundle branch, speaking to the innovations in more efficient ablation and pacing.
AI Momentum Remains – AI continued its strong presence at HRS, but this year it was all about integration and supporting modalities from ECG to periprocedural Echo. Almost all remote patients monitoring vendors and device data managers mentioned AI in their products in some way.
RPM Maturation – Speaking of RPM, the industry showed a lot of maturity this year, with established incumbents growing the market while innovative start-ups try to disrupt the space with new device form factors and data applications.
